UNITED THERAPEUTICS Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
42,833,193
Total 13F shares
40,884,780
Share change
-2,968,889
Total reported value
$17,141,521,441
Put/Call ratio
210%
Price per share
$419.21
Number of holders
701
Value change
-$1,065,484,238
Number of buys
314
Number of sells
351

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
12%
5,333,708
$1,532,641,018 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
10%
4,448,848
$1,278,376,474 30 Jun 2025
13F
Avoro Capital Advisors LLC
13F
Company
5.5%
2,370,000
$681,019,500 30 Jun 2025
13F
STATE STREET CORP
13D/G 13F
STATE STREET CORPORATION · Company
4.9%
2,199,994
$661,670,195 $0 31 Dec 2024
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.9%
2,119,092
$608,921,086 30 Jun 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.4%
1,442,936
$414,627,659 30 Jun 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
3%
1,273,161
$362,876,291 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.8%
1,200,365
$344,261,060 30 Jun 2025
13F
Invesco Ltd.
13F
Company
2.1%
884,703
$254,219,408 30 Jun 2025
13F
LSV ASSET MANAGEMENT
13F
Company
2%
864,623
$248,449,000 30 Jun 2025
13F
ASSETMARK, INC
13F
Company
1.7%
715,834
$205,694,828 30 Jun 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.3%
573,734
$164,853,543 30 Jun 2025
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.3%
540,626
$155,348,881 30 Jun 2025
13F
Pacer Advisors, Inc.
13F
Company
1.2%
509,737
$146,472,927 30 Jun 2025
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
1.1%
482,781
$138,727,118 30 Jun 2025
13F
NORGES BANK
13F
Company
1.1%
474,868
$136,453,320 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
1.1%
452,219
$129,945,130 30 Jun 2025
13F
FMR LLC
13F
Company
0.99%
424,240
$121,905,340 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.93%
397,514
$114,226,032 30 Jun 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.93%
396,655
$113,978,814 30 Jun 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
0.9%
387,046
$111,217,784 30 Jun 2025
13F
Amundi
13F
Individual
0.85%
362,826
$107,113,491 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.85%
362,471
$104,156,033 30 Jun 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.79%
339,092
$97,438,086 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.78%
335,885
$96,516,555 30 Jun 2025
13F
Swedbank AB
13F
Company
0.77%
330,617
$95,002,797 30 Jun 2025
13F
FIRST TRUST ADVISORS LP
13F
Company
0.71%
305,512
$87,789,001 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.69%
296,071
$85,076,002 30 Jun 2025
13F
Epoch Investment Partners, Inc.
13F
Company
0.68%
291,494
$83,760,801 30 Jun 2025
13F
AustralianSuper Pty Ltd
13F
Company
0.67%
287,845
$82,712,261 30 Jun 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.67%
285,068
$81,914,290 30 Jun 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.66%
281,523
$80,926,416 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
0.65%
276,480
$79,446,529 30 Jun 2025
13F
LORD, ABBETT & CO. LLC
13F
Company
0.64%
273,687
$78,644,000 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.59%
251,299
$72,210,768 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.57%
242,590
$69,708,237 30 Jun 2025
13F
Robeco Institutional Asset Management B.V.
13F
Company
0.55%
234,639
$67,423,515 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.5%
212,726
$61,126,816 30 Jun 2025
13F
Pictet Asset Management Holding SA
13F
Company
0.49%
211,417
$60,675,301 30 Jun 2025
13F
Soleus Capital Management, L.P.
13F
Company
0.49%
209,794
$60,284,306 30 Jun 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.48%
206,018
$59,173,000 30 Jun 2025
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.46%
198,583
$57,062,816 30 Jun 2025
13F
Legal & General Group Plc
13F
Company
0.46%
198,519
$57,044,433 30 Jun 2025
13F
Bridgewater Associates, LP
13F
Company
0.46%
195,118
$56,067,157 30 Jun 2025
13F
VIRGINIA RETIREMENT SYSTEMS ET Al
13F
Company
0.45%
194,000
$55,745,900 30 Jun 2025
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.43%
185,477
$53,296,000 30 Jun 2025
13F
HSBC HOLDINGS PLC
13F
Company
0.43%
184,794
$53,098,275 30 Jun 2025
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.4%
170,030
$48,858,121 30 Jun 2025
13F
COMERICA BANK
13F
Company
0.38%
161,980
$46,544,843 30 Jun 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.36%
152,727
$43,886,103 30 Jun 2025
13F

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2025

As of 30 Sep 2025, UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by 701 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,884,780 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Avoro Capital Advisors LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, Darwin Global Management, Ltd., and LSV ASSET MANAGEMENT. This page lists 702 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
662
Q3 2025 holders
701
Holder diff
39
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.